Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 23 locations
View Trial Details
Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NCT07503808

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +48 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START New York Long Island, LLC Lake Success, New York, United States
View all 15 locations
View Trial Details
Recruiting

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

NCT07261631

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +30 more
Locations
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Odense C, Denmark
  • Novartis Investigative Site Vandœuvre-lès-Nancy, France
  • Novartis Investigative Site Essen, Germany
View Trial Details
Recruiting

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

NCT05768932

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • University of Miami Health System Coral Gables, Florida, United States
  • Winship Cancer Institute / Emory University Atlanta, Georgia, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 17 locations
View Trial Details
Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

NCT07211178

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Birmingham Hematology Associates Birmingham, Alabama, United States
  • PIH Health Whittier Hospital Whittier, California, United States
  • Cleveland Clinic Florida Weston, Florida, United States
  • Southern Illinois Hospital Services Carbondale, Illinois, United States
View all 14 locations
View Trial Details

Related conditions